Metagenome-wide association study of the alterations in the intestinal microbiome composition of ankylosing spondylitis patients and the effect of traditional and herbal treatment

. Ankylosing spondylitis (AS) is a systemic progressive disease with an unknown etiology that may be related to the gut microbiome. Therefore, a more thorough understanding of its pathogenesis is necessary for directing future therapy. . We aimed to determine the differences in intestinal microbial...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical microbiology 2020-06, Vol.69 (6), p.797-805
Hauptverfasser: Huang, RunYue, Li, Fang, Zhou, Yingyan, Zeng, Zhenhua, He, Xiaohong, Fang, Lihua, Pan, Feng, Chen, Yile, Lin, Jiehua, Li, Jie, Qiu, Dongni, Tian, Yinping, Tan, Xi, Song, Yanni, Xu, Yongyue, Lai, Yonghui, Yi, Hao, Gao, Qiang, Fang, Xiaodong, Shi, Mingming, Zhou, Chu, Huang, Jinqun, He, Yi-Ting
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 805
container_issue 6
container_start_page 797
container_title Journal of medical microbiology
container_volume 69
creator Huang, RunYue
Li, Fang
Zhou, Yingyan
Zeng, Zhenhua
He, Xiaohong
Fang, Lihua
Pan, Feng
Chen, Yile
Lin, Jiehua
Li, Jie
Qiu, Dongni
Tian, Yinping
Tan, Xi
Song, Yanni
Xu, Yongyue
Lai, Yonghui
Yi, Hao
Gao, Qiang
Fang, Xiaodong
Shi, Mingming
Zhou, Chu
Huang, Jinqun
He, Yi-Ting
description . Ankylosing spondylitis (AS) is a systemic progressive disease with an unknown etiology that may be related to the gut microbiome. Therefore, a more thorough understanding of its pathogenesis is necessary for directing future therapy. . We aimed to determine the differences in intestinal microbial composition between healthy individuals and patients with AS who received and who did not receive treatment interventions. In parallel, the pathology of AS in each patient was analysed to better understand the link between AS treatment and the intestinal microbiota of the patients. . Sixty-six faecal DNA samples, including 37 from healthy controls (HCs), 11 from patients with untreated AS (NM), 7 from patients treated with nonsteroidal anti-inflammatory drugs (e.g. celecoxib; WM) and 11 from patients treated with Chinese herbal medicine (CHM), such as the Bushen-Qiangdu-Zhilv decoction, were collected and used in the drug effect analysis. All samples were sequenced using Illumina HiSeq 4000 and the microbial composition was determined. . Four species were enriched in the patients with AS: , , and (HC vs. NM,
doi_str_mv 10.1099/jmm.0.001107
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7451032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2319490710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-5c1e0a0f970de5dc3d41eea0f8a4a98a197d34efed79b26a48eeea1cb9b9ba173</originalsourceid><addsrcrecordid>eNpVkUFv1DAQhS0EotuFG2eUIwey2LGzji9IqIKCVMSlPVuOPdl1Sexge0H7u_iDnWZLReVD7HnvfRPNEPKG0Q2jSn24naYN3VDKGJXPyIoJyet2K8RzsqK0aepmy9ozcp7zLXok5-olOeNMyg7TK_L3OxSzgxAnqP94B5XJOVpvio-hyuXgjlUcqrJHYSyQlnqufFhKPhTIxQczVpO3KfYeMZWN0xyzXwiYNeHnccR32FV5jsEdR5RyNSMKQsmouwUGwwC2LN2ScUscuffqHlKP15LAlAkzr8iLwYwZXj981-Tmy-fri6_11Y_LbxefrmrLO1Hq1jKghg5KUgets9wJBoCFzgijOsOUdFzAAE6qvtka0QHKzPYKj8FRrcnHE3c-9BM4i62TGfWc_GTSUUfj9VMl-L3exd9aipZR3iDg3QMgxV8HHJWefLYwjiZAPGTdcKaEohLNa_L-ZMUx5pxgeGzDqL7fs8Y9a6pPe0b72_9_7dH8b7H8Do5krFM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2319490710</pqid></control><display><type>article</type><title>Metagenome-wide association study of the alterations in the intestinal microbiome composition of ankylosing spondylitis patients and the effect of traditional and herbal treatment</title><source>MEDLINE</source><source>Microbiology Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Huang, RunYue ; Li, Fang ; Zhou, Yingyan ; Zeng, Zhenhua ; He, Xiaohong ; Fang, Lihua ; Pan, Feng ; Chen, Yile ; Lin, Jiehua ; Li, Jie ; Qiu, Dongni ; Tian, Yinping ; Tan, Xi ; Song, Yanni ; Xu, Yongyue ; Lai, Yonghui ; Yi, Hao ; Gao, Qiang ; Fang, Xiaodong ; Shi, Mingming ; Zhou, Chu ; Huang, Jinqun ; He, Yi-Ting</creator><creatorcontrib>Huang, RunYue ; Li, Fang ; Zhou, Yingyan ; Zeng, Zhenhua ; He, Xiaohong ; Fang, Lihua ; Pan, Feng ; Chen, Yile ; Lin, Jiehua ; Li, Jie ; Qiu, Dongni ; Tian, Yinping ; Tan, Xi ; Song, Yanni ; Xu, Yongyue ; Lai, Yonghui ; Yi, Hao ; Gao, Qiang ; Fang, Xiaodong ; Shi, Mingming ; Zhou, Chu ; Huang, Jinqun ; He, Yi-Ting</creatorcontrib><description>. Ankylosing spondylitis (AS) is a systemic progressive disease with an unknown etiology that may be related to the gut microbiome. Therefore, a more thorough understanding of its pathogenesis is necessary for directing future therapy. . We aimed to determine the differences in intestinal microbial composition between healthy individuals and patients with AS who received and who did not receive treatment interventions. In parallel, the pathology of AS in each patient was analysed to better understand the link between AS treatment and the intestinal microbiota of the patients. . Sixty-six faecal DNA samples, including 37 from healthy controls (HCs), 11 from patients with untreated AS (NM), 7 from patients treated with nonsteroidal anti-inflammatory drugs (e.g. celecoxib; WM) and 11 from patients treated with Chinese herbal medicine (CHM), such as the Bushen-Qiangdu-Zhilv decoction, were collected and used in the drug effect analysis. All samples were sequenced using Illumina HiSeq 4000 and the microbial composition was determined. . Four species were enriched in the patients with AS: , , and (HC vs. NM, &lt;0.05); only was found to be significantly changed in the NM-HC comparison. No additional species were found in the HC vs. CHM analysis, which indicated a beneficial effect of CHM in removing the other three strains. was found to be significantly increased in the comparison between the HC and WM groups, along with four other species ( , Clostridiales bacterium 1_7_47FAA, and ). The patients with AS harboured more bacterial species associated with carbohydrate metabolism and glycan biosynthesis in their faeces. They also had bacterial profiles less able to biodegrade xenobiotics or synthesize and transport vitamins. . The gut microbiota of the patients with AS varied from that of the HCs, and the treatment had an impact on this divergence. Our data provide insight that could guide improvements in AS treatment.</description><identifier>ISSN: 0022-2615</identifier><identifier>EISSN: 1473-5644</identifier><identifier>DOI: 10.1099/jmm.0.001107</identifier><identifier>PMID: 31778109</identifier><language>eng</language><publisher>England: Microbiology Society</publisher><subject>Adolescent ; Adult ; Drugs, Chinese Herbal - therapeutic use ; Dysbiosis ; Gastrointestinal Microbiome ; Humans ; Metagenome ; Middle Aged ; Spondylitis, Ankylosing - drug therapy ; Spondylitis, Ankylosing - metabolism ; Spondylitis, Ankylosing - microbiology ; Young Adult</subject><ispartof>Journal of medical microbiology, 2020-06, Vol.69 (6), p.797-805</ispartof><rights>2020 The Authors 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-5c1e0a0f970de5dc3d41eea0f8a4a98a197d34efed79b26a48eeea1cb9b9ba173</citedby><cites>FETCH-LOGICAL-c384t-5c1e0a0f970de5dc3d41eea0f8a4a98a197d34efed79b26a48eeea1cb9b9ba173</cites><orcidid>0000-0002-0521-9154</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3744,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31778109$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, RunYue</creatorcontrib><creatorcontrib>Li, Fang</creatorcontrib><creatorcontrib>Zhou, Yingyan</creatorcontrib><creatorcontrib>Zeng, Zhenhua</creatorcontrib><creatorcontrib>He, Xiaohong</creatorcontrib><creatorcontrib>Fang, Lihua</creatorcontrib><creatorcontrib>Pan, Feng</creatorcontrib><creatorcontrib>Chen, Yile</creatorcontrib><creatorcontrib>Lin, Jiehua</creatorcontrib><creatorcontrib>Li, Jie</creatorcontrib><creatorcontrib>Qiu, Dongni</creatorcontrib><creatorcontrib>Tian, Yinping</creatorcontrib><creatorcontrib>Tan, Xi</creatorcontrib><creatorcontrib>Song, Yanni</creatorcontrib><creatorcontrib>Xu, Yongyue</creatorcontrib><creatorcontrib>Lai, Yonghui</creatorcontrib><creatorcontrib>Yi, Hao</creatorcontrib><creatorcontrib>Gao, Qiang</creatorcontrib><creatorcontrib>Fang, Xiaodong</creatorcontrib><creatorcontrib>Shi, Mingming</creatorcontrib><creatorcontrib>Zhou, Chu</creatorcontrib><creatorcontrib>Huang, Jinqun</creatorcontrib><creatorcontrib>He, Yi-Ting</creatorcontrib><title>Metagenome-wide association study of the alterations in the intestinal microbiome composition of ankylosing spondylitis patients and the effect of traditional and herbal treatment</title><title>Journal of medical microbiology</title><addtitle>J Med Microbiol</addtitle><description>. Ankylosing spondylitis (AS) is a systemic progressive disease with an unknown etiology that may be related to the gut microbiome. Therefore, a more thorough understanding of its pathogenesis is necessary for directing future therapy. . We aimed to determine the differences in intestinal microbial composition between healthy individuals and patients with AS who received and who did not receive treatment interventions. In parallel, the pathology of AS in each patient was analysed to better understand the link between AS treatment and the intestinal microbiota of the patients. . Sixty-six faecal DNA samples, including 37 from healthy controls (HCs), 11 from patients with untreated AS (NM), 7 from patients treated with nonsteroidal anti-inflammatory drugs (e.g. celecoxib; WM) and 11 from patients treated with Chinese herbal medicine (CHM), such as the Bushen-Qiangdu-Zhilv decoction, were collected and used in the drug effect analysis. All samples were sequenced using Illumina HiSeq 4000 and the microbial composition was determined. . Four species were enriched in the patients with AS: , , and (HC vs. NM, &lt;0.05); only was found to be significantly changed in the NM-HC comparison. No additional species were found in the HC vs. CHM analysis, which indicated a beneficial effect of CHM in removing the other three strains. was found to be significantly increased in the comparison between the HC and WM groups, along with four other species ( , Clostridiales bacterium 1_7_47FAA, and ). The patients with AS harboured more bacterial species associated with carbohydrate metabolism and glycan biosynthesis in their faeces. They also had bacterial profiles less able to biodegrade xenobiotics or synthesize and transport vitamins. . The gut microbiota of the patients with AS varied from that of the HCs, and the treatment had an impact on this divergence. Our data provide insight that could guide improvements in AS treatment.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Drugs, Chinese Herbal - therapeutic use</subject><subject>Dysbiosis</subject><subject>Gastrointestinal Microbiome</subject><subject>Humans</subject><subject>Metagenome</subject><subject>Middle Aged</subject><subject>Spondylitis, Ankylosing - drug therapy</subject><subject>Spondylitis, Ankylosing - metabolism</subject><subject>Spondylitis, Ankylosing - microbiology</subject><subject>Young Adult</subject><issn>0022-2615</issn><issn>1473-5644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkUFv1DAQhS0EotuFG2eUIwey2LGzji9IqIKCVMSlPVuOPdl1Sexge0H7u_iDnWZLReVD7HnvfRPNEPKG0Q2jSn24naYN3VDKGJXPyIoJyet2K8RzsqK0aepmy9ozcp7zLXok5-olOeNMyg7TK_L3OxSzgxAnqP94B5XJOVpvio-hyuXgjlUcqrJHYSyQlnqufFhKPhTIxQczVpO3KfYeMZWN0xyzXwiYNeHnccR32FV5jsEdR5RyNSMKQsmouwUGwwC2LN2ScUscuffqHlKP15LAlAkzr8iLwYwZXj981-Tmy-fri6_11Y_LbxefrmrLO1Hq1jKghg5KUgets9wJBoCFzgijOsOUdFzAAE6qvtka0QHKzPYKj8FRrcnHE3c-9BM4i62TGfWc_GTSUUfj9VMl-L3exd9aipZR3iDg3QMgxV8HHJWefLYwjiZAPGTdcKaEohLNa_L-ZMUx5pxgeGzDqL7fs8Y9a6pPe0b72_9_7dH8b7H8Do5krFM</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Huang, RunYue</creator><creator>Li, Fang</creator><creator>Zhou, Yingyan</creator><creator>Zeng, Zhenhua</creator><creator>He, Xiaohong</creator><creator>Fang, Lihua</creator><creator>Pan, Feng</creator><creator>Chen, Yile</creator><creator>Lin, Jiehua</creator><creator>Li, Jie</creator><creator>Qiu, Dongni</creator><creator>Tian, Yinping</creator><creator>Tan, Xi</creator><creator>Song, Yanni</creator><creator>Xu, Yongyue</creator><creator>Lai, Yonghui</creator><creator>Yi, Hao</creator><creator>Gao, Qiang</creator><creator>Fang, Xiaodong</creator><creator>Shi, Mingming</creator><creator>Zhou, Chu</creator><creator>Huang, Jinqun</creator><creator>He, Yi-Ting</creator><general>Microbiology Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0521-9154</orcidid></search><sort><creationdate>202006</creationdate><title>Metagenome-wide association study of the alterations in the intestinal microbiome composition of ankylosing spondylitis patients and the effect of traditional and herbal treatment</title><author>Huang, RunYue ; Li, Fang ; Zhou, Yingyan ; Zeng, Zhenhua ; He, Xiaohong ; Fang, Lihua ; Pan, Feng ; Chen, Yile ; Lin, Jiehua ; Li, Jie ; Qiu, Dongni ; Tian, Yinping ; Tan, Xi ; Song, Yanni ; Xu, Yongyue ; Lai, Yonghui ; Yi, Hao ; Gao, Qiang ; Fang, Xiaodong ; Shi, Mingming ; Zhou, Chu ; Huang, Jinqun ; He, Yi-Ting</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-5c1e0a0f970de5dc3d41eea0f8a4a98a197d34efed79b26a48eeea1cb9b9ba173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Drugs, Chinese Herbal - therapeutic use</topic><topic>Dysbiosis</topic><topic>Gastrointestinal Microbiome</topic><topic>Humans</topic><topic>Metagenome</topic><topic>Middle Aged</topic><topic>Spondylitis, Ankylosing - drug therapy</topic><topic>Spondylitis, Ankylosing - metabolism</topic><topic>Spondylitis, Ankylosing - microbiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, RunYue</creatorcontrib><creatorcontrib>Li, Fang</creatorcontrib><creatorcontrib>Zhou, Yingyan</creatorcontrib><creatorcontrib>Zeng, Zhenhua</creatorcontrib><creatorcontrib>He, Xiaohong</creatorcontrib><creatorcontrib>Fang, Lihua</creatorcontrib><creatorcontrib>Pan, Feng</creatorcontrib><creatorcontrib>Chen, Yile</creatorcontrib><creatorcontrib>Lin, Jiehua</creatorcontrib><creatorcontrib>Li, Jie</creatorcontrib><creatorcontrib>Qiu, Dongni</creatorcontrib><creatorcontrib>Tian, Yinping</creatorcontrib><creatorcontrib>Tan, Xi</creatorcontrib><creatorcontrib>Song, Yanni</creatorcontrib><creatorcontrib>Xu, Yongyue</creatorcontrib><creatorcontrib>Lai, Yonghui</creatorcontrib><creatorcontrib>Yi, Hao</creatorcontrib><creatorcontrib>Gao, Qiang</creatorcontrib><creatorcontrib>Fang, Xiaodong</creatorcontrib><creatorcontrib>Shi, Mingming</creatorcontrib><creatorcontrib>Zhou, Chu</creatorcontrib><creatorcontrib>Huang, Jinqun</creatorcontrib><creatorcontrib>He, Yi-Ting</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, RunYue</au><au>Li, Fang</au><au>Zhou, Yingyan</au><au>Zeng, Zhenhua</au><au>He, Xiaohong</au><au>Fang, Lihua</au><au>Pan, Feng</au><au>Chen, Yile</au><au>Lin, Jiehua</au><au>Li, Jie</au><au>Qiu, Dongni</au><au>Tian, Yinping</au><au>Tan, Xi</au><au>Song, Yanni</au><au>Xu, Yongyue</au><au>Lai, Yonghui</au><au>Yi, Hao</au><au>Gao, Qiang</au><au>Fang, Xiaodong</au><au>Shi, Mingming</au><au>Zhou, Chu</au><au>Huang, Jinqun</au><au>He, Yi-Ting</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metagenome-wide association study of the alterations in the intestinal microbiome composition of ankylosing spondylitis patients and the effect of traditional and herbal treatment</atitle><jtitle>Journal of medical microbiology</jtitle><addtitle>J Med Microbiol</addtitle><date>2020-06</date><risdate>2020</risdate><volume>69</volume><issue>6</issue><spage>797</spage><epage>805</epage><pages>797-805</pages><issn>0022-2615</issn><eissn>1473-5644</eissn><abstract>. Ankylosing spondylitis (AS) is a systemic progressive disease with an unknown etiology that may be related to the gut microbiome. Therefore, a more thorough understanding of its pathogenesis is necessary for directing future therapy. . We aimed to determine the differences in intestinal microbial composition between healthy individuals and patients with AS who received and who did not receive treatment interventions. In parallel, the pathology of AS in each patient was analysed to better understand the link between AS treatment and the intestinal microbiota of the patients. . Sixty-six faecal DNA samples, including 37 from healthy controls (HCs), 11 from patients with untreated AS (NM), 7 from patients treated with nonsteroidal anti-inflammatory drugs (e.g. celecoxib; WM) and 11 from patients treated with Chinese herbal medicine (CHM), such as the Bushen-Qiangdu-Zhilv decoction, were collected and used in the drug effect analysis. All samples were sequenced using Illumina HiSeq 4000 and the microbial composition was determined. . Four species were enriched in the patients with AS: , , and (HC vs. NM, &lt;0.05); only was found to be significantly changed in the NM-HC comparison. No additional species were found in the HC vs. CHM analysis, which indicated a beneficial effect of CHM in removing the other three strains. was found to be significantly increased in the comparison between the HC and WM groups, along with four other species ( , Clostridiales bacterium 1_7_47FAA, and ). The patients with AS harboured more bacterial species associated with carbohydrate metabolism and glycan biosynthesis in their faeces. They also had bacterial profiles less able to biodegrade xenobiotics or synthesize and transport vitamins. . The gut microbiota of the patients with AS varied from that of the HCs, and the treatment had an impact on this divergence. Our data provide insight that could guide improvements in AS treatment.</abstract><cop>England</cop><pub>Microbiology Society</pub><pmid>31778109</pmid><doi>10.1099/jmm.0.001107</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0521-9154</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2615
ispartof Journal of medical microbiology, 2020-06, Vol.69 (6), p.797-805
issn 0022-2615
1473-5644
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7451032
source MEDLINE; Microbiology Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Drugs, Chinese Herbal - therapeutic use
Dysbiosis
Gastrointestinal Microbiome
Humans
Metagenome
Middle Aged
Spondylitis, Ankylosing - drug therapy
Spondylitis, Ankylosing - metabolism
Spondylitis, Ankylosing - microbiology
Young Adult
title Metagenome-wide association study of the alterations in the intestinal microbiome composition of ankylosing spondylitis patients and the effect of traditional and herbal treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T01%3A34%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metagenome-wide%20association%20study%20of%20the%20alterations%20in%20the%20intestinal%20microbiome%20composition%20of%20ankylosing%20spondylitis%20patients%20and%20the%20effect%20of%20traditional%20and%20herbal%20treatment&rft.jtitle=Journal%20of%20medical%20microbiology&rft.au=Huang,%20RunYue&rft.date=2020-06&rft.volume=69&rft.issue=6&rft.spage=797&rft.epage=805&rft.pages=797-805&rft.issn=0022-2615&rft.eissn=1473-5644&rft_id=info:doi/10.1099/jmm.0.001107&rft_dat=%3Cproquest_pubme%3E2319490710%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2319490710&rft_id=info:pmid/31778109&rfr_iscdi=true